Results 101 to 110 of about 1,574,756 (175)

Methods available to assess therapeutic potential of fibrinolytic enzymes of microbial origin: a review

, 2018
Fibrinolytic enzymes are agents administered for the treatment of myocardial infarctions, strokes, cardiac and respiratory failure. Although several microorganisms are known to produce these fibrinolytic enzymes, only a few of such enzymes, along with ...
Sandeep B. Subramanya, Prasanna D. Belur, Anusha Krishnamurthy   +2 more
core   +1 more source

Purification and Characterization of a Novel Fibrinolytic Enzyme from Marine Bacterium Bacillus sp. S-3685 Isolated from the South China Sea

Marine Drugs
A novel fibrinolytic enzyme, BSFE1, was isolated from the marine bacterium Bacillus sp. S-3685 (GenBank No.: KJ023685) found in the South China Sea.
Zibin Ma, Jeevithan Elango, Jianhua Hao, Wenhui Wu   +3 more
doaj   +1 more source

The efficacy and safety of anti-fibrinolytic agents in blood management following peri-acetabular osteotomy: A meta-analysis. [PDF]

Medicine (Baltimore), 2018
Wang M, Tan H, Wu Z, Liang Y.
europepmc   +1 more source

Fibrinolytic system of guinea pig serum

, 1959
Comparative studies on 10 mammals showed that, in contrast to all the others, guinea pig serum alone, on precipitation with acetic acid, pH 5.3–5.4 at 4°C, yielded a euglobulin with high spontaneous fibrinolytic activity.
Zbigniew Latallo, Stefan Niewiarowski, Alfred L. Copley   +2 more
core   +1 more source

Direct Oral Anticoagulants Versus Vitamin K Antagonist in Elderly Patients With Atrial Fibrillation: Sometimes Less Is More, but Sometimes More Is More

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Arthur Allen, Geoffrey D. Barnes
doaj   +1 more source

Thermotolerant bacteria producing fibrinolytic enzyme

, 2018
Fibrinolytic enzyme is very useful protease in degrading fibrin for the treatment of thrombosis. Producing the fibrinolytic enzyme at industrial scale involves many steps that require the identified enzyme to be resistant to high temperature, especially ...
Amid, Azura, Ab. Shukor, Nurul Aqilah
core  

Empyema thoracis: Surgical management in children

Journal of Indian Association of Pediatric Surgeons, 2009
Empyema thoracis can produce significant morbidity in children if inadequately treated. Correct evaluation of the stage of the disease, the clinical condition of the child and proper assessment of the response to conservative treatment is crucial in ...
Menon Prema, Kanojia Ravi, Rao K.L.N
doaj  

Fibrinolytic agents for peripheral arterial occlusion. [PDF]

Cochrane Database Syst Rev, 2013
Robertson I, Kessel DO, Berridge DC.
europepmc   +1 more source

Estudo de fatores pró-trombóticos e pró-inflamatórios na cardiomiopatia chagásica Study of pro-thrombotic and pro-inflammatory factors in chagas cardiomyopathy

Arquivos Brasileiros de Cardiologia, 2010
FUNDAMENTO: A relação entre atividade inflamatória e pró-trombótica na cardiomiopatia chagásica e em outras etiologias é obscura. OBJETIVO: Estudar o perfil de marcadores pró-trombóticos e pró-inflamatórios em pacientes com insuficiência cardíaca ...
Leila Maria Magalhães Pessoa de Melo, Germano Emílio Conceição Souza, Leandro Richa Valim, Luiz Felipe Pinho Moreira, Elbio Antonio Damico, Tania Rubia Flores da Rocha, Antonio Carlos Pereira Barretto, Celia Maria Cassaro Strunz, Edimar Alcides Bocchi, José Antonio Franchini Ramires   +9 more
doaj  

Combining antithrombotic and fibrinolytic agents: can it be done? [PDF]

Stroke, 2013
Khatri P, Mono ML.
europepmc   +1 more source